Efficacy and safety of flavocoxid compared with naproxen in subjects with osteoarthritis of the knee - A subset analysis

Advances in Therapy

Volumn 27, Issue 12, 2010, Pages 953-962

  Levy, Robert ^a   Khokhlov, Alexander ^b   Kopenkin, Sergey ^c   Bart, Boris ^c   Ermolova, Tatiana ^d   Kantemirova, Raiasa ^e   Mazurov, Vadim ^d   Bell, Marjorie ^f   Caldron, Paul ^g   Pillai, Lakshmi ^a   Burnett, Bruce ^a  

^a Primus Pharmaceuticals   (United States)

^b Yaraslavl Staate Medical Academy   (Russian Federation)

^c PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^d NORTH WESTERN STATE MEDICAL UNIVERSITY NAMED AFTER I I MECHNIKOV   (Russian Federation)

^e and Rehabilitation of Disabled Persons   (Russian Federation)

^f ClinDataServices   (United States)

^g Arizona Arthritis and Rheumatology Research   (United States)

Author keywords

5 lipoxygenase; clinical trial; cyclooxygenase; flavocoxid; flavonoids; osteoarthritis

Indexed keywords

ANTIINFLAMMATORY AGENT; FLAVOCOXID; NAPROXEN; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FUNCTIONAL ASSESSMENT; HUMAN; JOINT MOBILITY; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SYMPTOM; TREATMENT DURATION; TREATMENT RESPONSE; WALKING SPEED;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CATECHIN; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; HUMANS; KNEE JOINT; MALE; MIDDLE AGED; NAPROXEN; OSTEOARTHRITIS, KNEE; PAIN; PAIN MEASUREMENT; TREATMENT OUTCOME;

EID: 79251634664     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12325-010-0083-9     Document Type: Article

References (24)

1. Lozada CJ, Altman RD. Management of osteoarthritis. In: Koopman WJ, ed. Arthritis and Allied Conditions. Baltimore, MD: Lippincott, Williams and Wilkins; 2001:2246-2263.
2. F. Salaffi M. Carotti A. Stancati W. Grassi 2005 Health-related quality of life in older adults with symptomatic hip and knee osteoarthritis: a comparison with matched healthy controls Aging Clin Exp Res. 17 255 263 16285189
3. J.E. Sale M. Gignac G. Hawker 2008 The relationship between disease symptoms, life events, coping and treatment, and depression among older adults with osteoarthritis J Rheumatol. 35 335 342 18203312
4. O. Ethgen P. Vanparijs S. Delhalle S. Rosant O. Bruyere J.Y. Reginster 2004 Social support and health-related quality of life in hip and knee osteoarthritis Qual Life Res. 13 321 330 1:STN:280:DC%2BD2c7ovF2iuw%3D%3D 10.1023/B:QURE.0000018492.40262.d1 15085904
5. C. Jinks K. Jordan P. Croft 2007 Osteoarthritis as a public health problem: the impact of developing knee pain on physical function in adults living in the community: (KNEST 3) Rheumatology (Oxford) 46 877 881 1:STN:280:DC%2BD2s3jvVOrsQ%3D%3D 10.1093/rheumatology/kem013
6. B.P. Burnett R. Levy B.J. Cole 2006 Metabolic mechanisms in the pathogenesis of osteoarthritis. A review J Knee Surgery 19 191 197
7. D. Altavilla F. Squadrito A. Bitto 2009 Flavocoxid, a dual inhibitor of cyclooxygenase and 5-lipoxygenase, blunts pro-inflammatory phenotype activation in endotoxin stimulated macrophages Br J Pharmacol. 157 1410 1418 1:CAS:528:DC%2BD1MXhsVKmu7rM 10.1111/j.1476-5381.2009.00322.x 19681869
8. B.P. Burnett Q. Jia Y. Zhao R.M. Levy 2007 A medicinal extract of Scutellaria baicalensis and Acacia catechu acts as a dual inhibitor of cyclooxygenase and 5-lipoxygenase to reduce inflammation J Med. Foods 10 442 451 1:CAS:528:DC%2BD2sXhtVOgt77P 10.1089/jmf.2006.255
9. M. Yimam Y. Zhao W. Maa Q. Jia S.G. Do J.H. Shin 2010 90-Day oral toxicity study of UP446, a combination of defined extracts of Scutellaria baicalensis and Acacia catechu, in rats Food Chem Toxicol. 48 1202 1209 1:CAS:528:DC%2BC3cXks1Shsrg%3D 10.1016/j.fct.2010.02.011 20171255
10. S. Messina A. Bitto M. Aguennouz 2009 Flavocoxid counteracts muscle necrosis and improves functional properties in mdx mice: a comparison study with methylprednisolone Exp. Neurol. 220 349 58 1:CAS:528:DC%2BD1MXhsVGnt73I 10.1016/j.expneurol.2009.09.015 19786019
11. Burnett BP, Pillai L, Levy RM, editors. Flavocoxid, a natural novel flavonoid-based anti-inflammatory with a broad mechanism of action provides safe and effective inflammatory management of disease. Phoenix, AZ: Society for Biomolecular Science; 2010;11-15.
12. B.P. Burnett S. Silva M.H. Mesches Q. Jia 2007 Safety evaluation of a combination, defined extract of Scutellaria baicalensis and Acacia catechu J Food Biochem. 31 797 825 1:CAS:528:DC%2BD1cXjs1aisQ%3D%3D 10.1111/j.1745-4514. 2007.00142.x
13. Levy RM, Khokhlov A, Kopenkin S, et al. Efficacy and safety of flavocoxid, a novel therapeutic, compared with naproxen: a randomized multicenter controlled trial in subjects with osteoarthritis of the knee. Adv Ther. 2010. [Epub ahead of print].
14. S.S. Shapiro M.B. Wilk 1965 An analysis of variance test for normality (complete samples) Biometrika 52 591 611
15. No authors listed. COX-2 Selective (includes Bextra, Celebrex, and Vioxx) and Non-Selective Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). Available at: http://www.fda.gov/cder/drug/infopage/COX2/default.htm. Last accessed October 11, 2010.
16. M.R. Griffin J.M. Piper J.R. Daugherty M. Snowden W.A. Ray 1991 Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons Ann Intern Med. 114 257 263 1:STN:280: DyaK3M7gtlCntw%3D%3D 1987872
17. J.H. Gurwitz J. Avorn D. Ross-Degnan L.A. Lipsitz 1990 Nonsteroidal anti-inflammatory drug-associated azotemia in the very old JAMA 264 471 475 1:STN:280:DyaK3czgvVyqtw%3D%3D 10.1001/jama.264.4.471 2366280
18. P.A. Dieppe L.S. Lohmander 2005 Pathogenesis and management of pain in osteoarthritis Lancet 365 965 973 1:CAS:528:DC%2BD2MXitlOhtL0%3D 10.1016/S0140-6736(05)71086-2 15766999
19. K. Walker-Bone K. Javaid N. Arden C. Cooper 2000 Regular review: medical management of osteoarthritis BMJ 321 936 940 1:STN:280:DC%2BD3M%2FjtVahsA%3D%3D 10.1136/bmj.321.7266.936 11030685
20. D.T. Felson R.C. Lawrence P.A. Dieppe 2000 Osteoarthritis: new insights. Part 1: the disease and its risk factors Ann Intern Med. 133 635 646 1:STN:280:DC%2BD3M%2Fht1SitA%3D%3D 11033593
21. D.T. Felson R.C. Lawrence M.C. Hochberg 2000 Osteoarthritis: new insights. Part 2: treatment approaches Ann Intern Med. 133 726 737 1:STN:280:DC%2BD3M%2FivFKktg%3D%3D 11074906
22. M. Fiorani A. Accorsi O. Cantoni 2003 Human red blood cells as a natural flavonoid reservoir Free Radical Res. 37 1331 1338 1:CAS:528: DC%2BD3sXpsVCls7s%3D 10.1080/10715760310001615998
23. R.J. Naftalin I. Afzal P. Cunningham 2003 Interactions of androgens, green tea catechins and the antiandrogen flutamide with the external glucose-binding site of the human erythrocyte glucose transporter GLUT1 Br J Pharmacol. 140 487 499 1:CAS:528:DC%2BD3sXosFOgs7k%3D 10.1038/sj.bjp.0705460 12970085
24. M. Fiorani A. Accorsi O. Cantoni 2003 Human red blood cells as a natural flavonoid reservoir Free Radic Res. 37 1331 1338 1:CAS:528:DC%2BD3sXpsVCls7s%3D 10.1080/10715760310001615998 14753757